The vitiligo is an autoimmune disease characterized by the destruction of melanocytes, the cells responsible for melanin production, thereby causing depigmentation in certain areas of the body. Although genetic predispositions play a major role in its development, several environmental factors may also promote the onset of vitiligo. Among these, sun exposure is cited as a potential trigger, due to the oxidative stress it can induce within melanocytes.
However, phototherapy is one of the most commonly used approaches to promote repigmentation of vitiligo lesions.
PUVA phototherapy, combining psoralen and UVA radiation, acts by modulating the immune response, notably by reducing T-cell activity. Meanwhile, narrowband UVB (NB-UVB) phototherapy stimulates the proliferation and migration of melanocytes still present in adjacent areas. However, uncontrolled sun exposure can trigger sunburns or localized inflammation, which may exacerbate existing lesions, particularly via the Koebner phenomenon, where skin trauma leads to the development of new patches.
A study conducted on 442 vitiligo patients, distributed across various phototypes (I to VI), examined their perception of sun-exposure risk. Among them, 86 patients reported that their patches appeared more visible after exposure, and 113 thought their depigmented areas were more vulnerable to sunburn. These findings reflect a common experience among patients. Moreover, many of them often believe that vitiligo increases the risk of developing melanoma.
Contrary to what one might assume, vitiligo appears to diminish cancer occurrence, since the autoimmunity induced in vitiligo seems to confer protection against melanomas. Additionally, vitiligo patients often demonstrate better reflexes in photoprotection.
Indeed, a large-scale study conducted in 2014 analyzed a cohort of 10,040 vitiligo patients to assess their risk of skin cancer compared with a control group. The results revealed a significantly lower incidence of skin cancer among individuals with vitiligo. However, the study also highlighted a higher risk of skin cancers in patients who had undergone phototherapy sessions (14.1% versus 3.2%).